The AIFM1 gene helps cells make energy inside mitochondria, which are the parts of cells that act like tiny power plants. This gene plays an important role in keeping energy hungry tissues working, especially the brain, nerves, muscles, and inner ear. If the AIFM1 gene does not work properly, these tissues may not get the energy they need. Pathogenic variants in the AIFM1 gene are linked to several inherited conditions that can include developmental delay, muscle weakness, hearing loss, balance problems, seizures, or nerve symptoms.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mostly help determine when specific processes happen, where they take place, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you respond to food, stress, or medicines. For a more detailed explanation, you can visit the LearnHub.
Overview
AIFM1Gene function
What if the gene works
The AIFM1 gene helps mitochondria, the parts of cells that make energy, work properly. It also supports cell survival and normal responses to stress.
Risk
What if the gene does not work
Variants in the AIFM1 gene often affect the brain, nerves, muscles, and hearing. Effects can range from hearing loss or neuropathy to early developmental problems, weakness, and seizures, with milder or more severe variants influencing onset and severity.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by pathogenic variants in the AIFM1 gene. The AIFM1 gene is being studied as a cell death pathway target and possible biomarker, but this has not yet led to routine guideline-based treatment.
Conditions associated with AIFM1
Gene function
What if the gene works
Much of AIFM1's day-to-day work happens inside mitochondria, the parts of cells that turn food into usable energy. It helps keep energy production steady and supports the normal upkeep of these structures. AIFM1 also takes part in the body’s controlled process for clearing out cells when needed. Understanding AIFM1 gene function helps explain how cells stay powered and balanced over time.
AIFM1 helps mitochondria carry out key energy-making steps so cells can produce ATP, the fuel they use every day. This steady energy supply supports routine work in tissues throughout the body.
AIFM1 helps maintain the inner structure of mitochondria, including the folded surfaces where energy-making reactions occur. It also supports other mitochondrial proteins as they become ready to do their jobs.
AIFM1 can join the body’s programmed cell death process (a built-in way to remove cells at the right time). This helps with normal development, tissue renewal, and overall cell balance.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can affect a gene’s function more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AIFM1 gene can change the protein's shape, make it less stable, or weaken how well it binds helper molecules and partner proteins inside mitochondria, the cell's energy centers. This is how variants in the AIFM1 gene affect protein function: some changes leave partial activity, while more severe variants can markedly reduce protein levels or disrupt its movement within the cell. That range often influences how early symptoms begin and how pronounced they are in linked mitochondrial conditions.
How variants are linked to conditions
Pathogenic variants in the AIFM1 gene cause a spectrum of rare X-linked conditions. This includes hearing loss with peripheral neuropathy, childhood or adult onset ataxia, muscle weakness, developmental delay, and a more severe infantile condition often called combined oxidative phosphorylation deficiency 6. In practice, AIFM1 gene variants linked to conditions can affect people quite differently, even within the same family.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are common throughout the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition indicates a possible association, not a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the AIFM1 gene. Risk and symptoms can vary a lot depending on the exact gene change and the person’s sex, so personal guidance from a doctor or genetic counselor is important.
Inheritance of AIFM1 variants
AIFM1-related conditions are inherited in an X-linked pattern, so the AIFM1 inheritance pattern differs for sons and daughters. A mother carrying an AIFM1 variant can pass it to either a son or a daughter, while a father with the variant passes it to all daughters and to no sons. Males often have more noticeable effects because they have one X chromosome, but some females who carry an AIFM1 variant can also have symptoms.
What does my AIFM1 result mean for my family?
AIFM1-related conditions usually run in families through the X chromosome, so the result can matter for close relatives on your mother’s side as well as your children. Male relatives may be more likely to have symptoms, while female relatives may carry the change and can sometimes have milder features. Parents, siblings, and other close family members may also want to talk with their care team about whether this result could apply to them.
Genetic information
Genetic testing
How you find out about variants
To find variants in the AIFM1 gene, doctors use genetic testing on blood, saliva, or a cheek swab. AIFM1 genetic testing reads the gene’s DNA code with a panel test, exome sequencing, or genome sequencing and compares it with a reference. Results may show a disease-causing variant, a likely benign change, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider AIFM1 testing if there is a family history of an inherited condition affecting nerves or the body’s energy supply, especially when boys or men are more affected. It can also help explain unexplained hearing loss, muscle weakness, balance problems, seizures, or developmental delay that starts in childhood.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Factors such as age, lifestyle, environment, and medical history also shape how the body functions over time. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work well for one person but less well for another. These differences can change how quickly a drug is broken down, how strongly it acts, or how likely side effects are. This is a common part of human biology and one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medicines. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can affect both how strongly a drug works and how the body processes it. This understanding can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the AIFM1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response in everyday medical care. For questions about symptoms, treatment choices, or side effects, it is best to speak with your doctor or pharmacist.
History
The AIFM1 gene entered medical research through studies of how cells die in a controlled way, an area that expanded rapidly in the 1990s. In 1999, researchers identified its protein product as “apoptosis inducing factor,” linking it to a major shift in cell death research. Building on this early work, scientists uncovered more about the gene. During the 2000s, AIFM1 was also connected to inherited conditions affecting the nerves, muscles, and hearing, which broadened its importance beyond basic laboratory science. As genetic testing became more widely used, more families with AIFM1 variants were recognized, and the clinical picture became clearer. Over time, scientists’ understanding of the gene’s role has changed, moving from a narrow focus on cell death to a wider view of human disease.